Biovail Included in Toronto Stock Exchange - TSE - 100 Index; Listing to Commence November 17, 1998.

TORONTO, Canada--(BW HealthWire)--Nov. 16, 1999--

Biovail Corporation International (NYSE NYSE

See: New York Stock Exchange :BVF BVF Biovail Corporation (stock symbol)
BVF Berufsverband der Frauenärzte eV (Muenchen, Germany)
BVF Bearing Versus Frequency )(TSE See Tokyo Stock Exchange.

TSE

1. See Tokyo Stock Exchange (TSE).

2. See Toronto Stock Exchange (TSE). :BVF) announced today that it has received notification that the Company will be added to the consumer sector of the TSE 100 Index, effective Wednesday, November 17, 1999.

Biovail Corporation International is an international full-service pharmaceutical company, engaged in the formulation, clinical testing, registration and manufacture of drug products utilizing advanced drug delivery technologies.

"Safe Harbor" statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995.

To the extent any statements made in this release contain information that is not historical, these statements are essentially forward looking and are subject to risks and uncertainties, including the difficulty of predicting FDA FDA
abbr.
Food and Drug Administration

FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration. approvals, acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, new product development and launch, reliance on key strategic alliances, availability of raw materials, the regulatory environment, fluctuations in operating results and other risks detailed from time to time in the company's filings with the Securities and Exchange Commission.

COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.

Reader Opinion

Article Details
Printer friendly Cite/link Email Feedback
Publication:	Business Wire
Geographic Code:	1CANA
Date:	Nov 16, 1999
Words:	167
Previous Article:	Roadway Express' Wickham Selected Logistics Executive of the Year.
Next Article:	Cimage Enterprise Systems Acquires the Assets of NovaSoft Systems.
Topics:	Drugs Pharmaceutical industry

Related Articles
Biovail announces 3-for-1 stock split.
Biovail Closes $125 Million Senior Note Offering.
CLARIFICATION of BW1847, BIOVAIL-CORPORATION from Nov. 16; Biovail Closes U.S. $125 Million Senior Note Offering.
Biovail and Fuisz Announce Results of Tender Offer.
Biovail / Fuisz Merger Approved.
Biovail Announces Proposed Stock Split and the Expiration of Biovail Technologies Ltd.'s Offer to Purchase Its Outstanding 7% Convertible...
The Investment Reporter beats the Toronto Stock Exchange 300 composite.
FDA APPROVES BIOVAIL'S GENERIC PROCARDIA XL 30MG DOSAGE.
Biovail Included in Toronto Stock Exchange --TSE-- 35 Index; Listing to Commence May 11, 2001.
Rubicon Minerals graduates to TSE.